baber/WOPTO huggingface dataset:
Patent EP-0822920-B1 (EP)
Inventor: KUEKE FRITZ
IPC: C02F1/72
Filed: 1996-04-24
Granted: 2001-10-04
Abstract: The present process proceeds from an aqueous reaction solution containing a chlorite and a halogen-free oxidizing agent which is present in an excess of up to double the required stoichiometric amount. The pH of the reaction solution is set at between 5.5 and 9.5, preferably between 6 and 9, and the reaction solution is reacted at ambient temperature until almost all the chlorite has been converted into chlorine dioxide. In this way a chlorine dioxide-containing solution is obtained which is free not only from residual chlorite but also from chlorate and other undesirable by-products and can be used directly as such in water treatment. Preferably an aqueous chlorite solution with a pH or more than 9.5 and an aqueous solution of the oxidizing agent are mixed with one another in order to produce the reaction solution, the pH of the aqueous mixture being adjusted by means of a proton donor present in the oxidizing agent solution. In this way a two-component reaction product is advantageously obtained which need only be mixed in a pre-determined ratio in order to produce a fresh chlorate-free chlorine dioxide solution. It is further advantageous to add to the aqueous chlorite solution or aqueous oxidizing agent solution a buffer substance which forms a buffer system which is active between pH 5.5 and pH 9.5 in the aqueous mixture, thus further stabilizing the pH set. The preferred presence of at least catalytic amounts of silver ions or ions of other transition metals in the reaction solution has a positive effect on the conversion of chlorite ions into chlorine dioxide.
Patent EP-0830062-B1 (EP)
Inventor: STOCKHOFF BRIAN
IPC: A01N63/50
Filed: 1996-06-07
Granted: 2003-03-05
Abstract: The subject invention concerns the use of Bacillus thuringiensis (B.t.) endotoxins to control hemipteran insect pests. Specifically exemplified is B.t. strain 201T6, B.t. var. israelensis, and  delta -endotoxins therefrom. These isolates and toxins can be administered to said pests, or to the environment of said pests, e.g., plants, to achieve control of the pests. A preferred embodiment is the transformation of plants to express the B.t. toxins.
Patent EP-0836632-B1 (EP)
Inventor: TICKTIN ANTON
IPC: C08L33/22
Filed: 1996-07-02
Granted: 1999-09-29
Abstract: L'invention concerne des matières de moulage thermoplastiques comprenant A) entre 98 et 99,995% en poids, par rapport à A + B, d'au moins un polymère contenant de l'acrylnitrile et B) entre 0,005 et 2 % en poids, par rapport à A + B, d'α-tocophérol. L'invention concerne en outre un procédé permettant de réduire la formation de monomères résiduels lors de la sollicitation thermique et du cisaillement des matières de moulage thermplastiques par adjonction d'α-tocophérol.
Patent EP-0930819-B1 (EP)
Inventor: MACGUINNESS THOMAS PETER
IPC: A01K13/00
Filed: 1996-12-18
Granted: 2004-06-02
Abstract: A horse rug with a front closure for securing the rug to a horse when the opposed front edges of the rug are brought together. The point of closure is positioned, in use, not lower than the point of shoulder of the horse. The rug is provided with strips of webbing on each of its front edges respectively, which form a part of the closure. The strips of webbing define an angle of between 40° and 70° causing the front of the rug to exhibit a collar effect about the neck of the horse. The angle being adapted to accommodate at its interior the point of shoulder of the horse, such that the closure, and thereby the front of the rug, is maintained in position relative to the point of shoulder while the horse undergoes its normal movements. The horse rug is designed so as to accommodate the structure of the shoulder of the horse and thus obviates problems of rubbing and interference with the natural movement of the horse occurring with conventional horse rugs.
Patent EP-0794254-B1 (EP)
Inventor: MAGOTA KOJI
IPC: C12N1/19
Filed: 1997-03-04
Granted: 2008-10-01
Abstract: Kex2 protease derivatives obtained by transforming methanol-assimilating with expression vectors containing DNA coding for any amino acid sequence which is an amino acid sequence of Kex2 protease wherein the N-terminus is the Met at position 1 and the C-terminus is one of the amino acids between positions 618 (inclusive) and 698 (inclusive), or a modification of that amino acid sequence, culturing the resulting transformants and recovering the derivatives from the cultures, as well as gene systems coding for the derivatives and a method for producing the Kex2 protease derivatives using the gene systems. Also, a method for excision of desired peptides using the Kex2 protease derivatives.
Patent EP-0811850-B1 (EP)
Inventor: MANHAEVE HANS
IPC: G01R31/26
Filed: 1997-05-29
Granted: 2005-07-27
Abstract: The present invention relates to a system for the measurement of a supply current of an electronic circuit, comprising:   a first part with control means for applying and controlling at least one voltage and one current on said circuit; a second part being fed by an input voltage and delivering a first output voltage and a first output current on a first terminal and a second output current on a second terminal, said first output voltage being essentially equal to said input voltage, said second output current being essentially proportional to said first output current being said supply current; a switch in between said first and said second part, being controlled by trigger means controlled by said first part, for turning said switch off or on whereby switching said second part in measurement mode or in bypass mode.   <IMAGE>
Patent EP-0880345-B1 (EP)
Inventor: DOWD MICHAEL
IPC: A61F2/46
Filed: 1997-01-16
Granted: 2006-04-05
Abstract: A process for fabricating shaped material from demineralized bone particles includes the steps of applying a liquid slurry of demineralized bone particles to a support, removing excess liquid form the demineralized bone particles to provide a cohering shaped mass of demineralized bone particles, and warming the shaped mass of demineralized bone particles at a predetermined temperature and for a predetermined time period. The resultant bone mass exhibits enhanced tensile strength and minimal bone particle disassociation upon rehydration thereby improving product handling and application at the operative site.
Patent EP-0894038-B1 (EP)
Inventor: BROGAARDH TORGNY
IPC: B25J11/00
Filed: 1997-03-14
Granted: 2002-08-14
Abstract: A device for relative movement of two elements comprises two link arrangements coupled in series using a connection arrangement. A first link arrangement comprises at least three links which are substantially equal in length and parallel. The links are positioned in a substantially triangular relation viewed along the longitudinal direction of the links, between the connection arrangement and a second of the elements. A second link arrangement comprises at least one parallelogram acting between the connection arrangement and a first of the elements. First and second force applying arrangements are adapted to cause the first link arrangement to pivot. A third force applying arrangement is adapted to cause the second link arrangement to pivot.
Patent EP-0895784-B1 (EP)
Inventor: SUGAWARA SHUICHI
IPC: A61K47/48
Filed: 1997-04-15
Granted: 2005-11-23
Abstract: Disclosed is a drug complex of a drug having a hydroxyl group, which is capable of controlling the rate of the release of the drug therefrom in blood, the drug complex being represented by the following formula (1): <CHEM> wherein A represents at least one carrier selected from the group consisting of saccharides each having a carboxyl group, polyethylene glycols each having a carboxyl group, aliphatic carboxylic acids each having a carboxyl group, and derivatives thereof each having a carboxyl group; B represents at least one spacer comprised of a compound having a amino group and a carboxyl group; C represents at least one drug having a hydroxyl group, wherein the carrier A is bonded to the spacer B through an amide bond formed between the carboxyl group of the carrier A and the amino group of the spacer B; and the spacer B is bonded to the drug C through an ester bond formed between the carboxyl group of the spacer B and the hydroxyl group of the drug C. The drug complex of the present invention is capable of not only surely controlling the rate of release of the drug therefrom, but also enhancing the transferability of the drug to target tissues and the pharmacological effect of the drug.
Patent EP-0895517-B1 (EP)
Inventor: LOUGHMAN THOMAS CIARAN
IPC: C08L101/16
Filed: 1997-04-22
Granted: 2004-11-17
Abstract: Methods of preparing biodegradable polyesters containing lactic acid units and/or glycolic acid units and optionally other hydroxy acids are provided, as well as biodegradable polyesters comprising lactic acid units and glycolic acid units and an initiator.
Patent EP-1019526-B1 (EP)
Inventor: GAGE PETER WILLIAM
IPC: C12Q1/02
Filed: 1997-09-26
Granted: 2006-05-10
Abstract: A method for determining the ion channel activity of a substance comprises the steps of (i) expressing the substance as a heterologous protein in a host cell, and (ii) determining changes in permeability of the plasma membrane of the host cell induced by expression of the heterologous protein. A screening method for determining ion channel modulating activity of a test substance is also disclosed.
Patent EP-0904128-B1 (EP)
Inventor: JAERNSTROEM RISTO
IPC: A61N1/30
Filed: 1997-05-27
Granted: 2004-01-14
Abstract: The present invention relates to a pharmaceutical composition for the controlled iontophoretic transdermal delivery of a drug comprising a combination of a drug and an electrically conductive carrier, wherein the administration of the drug to the patient is intended to be enhanced by leading an electrical current from said composition to the patient's skin. According to the invention the electrically conductive carrier is a textile fiber with an ion exchanger group grafted thereto. According to a preferred embodiment the drug is tacrine or its pharmaceutically acceptable salt. The invention further concerns a system for the iontophoretic transdermal delivery of a drug to a patient. In this system, the pharmaceutical composition (22) is attached to the patient's skin and used as one of the poles connected to a source (30) of direct current.
Patent EP-0906247-B1 (EP)
Inventor: EVANS IAN DAVID
IPC: C02F3/06
Filed: 1997-05-28
Granted: 2003-09-17
Abstract: A wastewater treatment system comprises a fixed bed aeration zone (20, 30) and, upstream of the aeration zone, a moving bed biofilm reactor zone (10). Typically, the reactor zone comprises a buoyant medium (11) and a forced oxygen supply (13).
Patent EP-0901454-B1 (EP)
Inventor: BORCHERT HOLGER
IPC: B01J23/656
Filed: 1997-05-16
Granted: 2000-11-08
Abstract: PCT No. PCT/EP97/02522 Sec. 371 Date Nov. 19, 1998 Sec. 102(e) Date Nov. 19, 1998 PCT Filed May 16, 1997 PCT Pub. No. WO97/44299 PCT Pub. Date Nov. 27, 1997A process for the selective preparation of acetic acid from a gaseous feed comprising ethane, ethylene or mixtures thereof plus oxygen at elevated temperature, which comprises bringing the gaseous feed into contact with a catalyst comprising the elements Mo, Pd, Re, X and Y in gram atom ratios a:b:c:d:e in combination with oxygenMoaPdbRecXdYe(I)where the symbols X, Y have the following meanings: X=Cr, Mn, Nb, B, Ta, Ti, V and/or W Y=Bi, Ce, Co, Cu, Te, Fe, Li, K, Na, Rb, Be, Mg, Ca, Sr, Ba, Ni, P, Pb, Sb, Si, Sn, Tl and/or U; the indices a, b, c, d and e are the gram atom ratios of the corresponding elements, where a=1, b>0, c>0, d=0.05-2, e=0-3.
Patent EP-0912492-B1 (EP)
Inventor: DURY MICHEL
IPC: C07C209/62
Filed: 1997-07-16
Granted: 2002-09-25
Abstract: The halogenation of a compound of formula (1) or formula (2'), wherein Q is an NH2 group optionally in the form of an addition salt, or an NHCOCH3 group, and X is a halogen atom, using a compound of formula X2, in a solvent selected from an anhydrous halogenated hydrocarbon, a mixture of water and a halogenated hydrocarbon and optionally the compound of formula (1) itself, gives a 2-amino or 2-acetamido trifluoromethylbenzene halogenated in the 5 position of the benzene ring.
Patent EP-0931054-B1 (EP)
Inventor: LUYKEN HERMANN
IPC: C07C209/86
Filed: 1997-08-28
Granted: 2003-05-28
Abstract: Verfahren zur Abtrennung von 2-Aminomethylcyclopentylamin aus einer Mischung enthaltend Hexamethylendiamin und 2-Aminomethylcyclopentylamin, dadurch gekennzeichnet, daß man die Trennung destillativ bei einem Druck von 1 bis 300 mbar durchführt.
Patent EP-1007011-B1 (EP)
Inventor: NEWKOME GEORGE R
IPC: A61K47/48
Filed: 1997-08-26
Granted: 2006-12-27
Abstract: A lock unimolecular micelle includes at least one engineered acceptor specifically binding a ligand (or specifically a "key" unimolecular micelle) thereto. A key unimolecular micelle comprises a core molecule and a plurality of branches extending therefrom, at least one of the branches including a shank portion extending therefrom having a terminal moiety at an end thereof for binding to a complimentary acceptor of a lock unimolecular micelle. Together, the lock and key micelles form a unit, either irreversibly or reversibly bound wherein the lock micelle is a soluble receptor engineered to specifically bind to the specifically engineered key micelle.
Patent EP-1037754-B1 (EP)
Inventor: PARRISH GARY CHARLES
IPC: G08C25/00
Filed: 1997-12-09
Granted: 2002-08-14
Abstract: Un dispositif (12) associé à un pneumatique (10) est enfermé dans un matériau élastomère (16) situé dans la région toroïdale du pneumatique (10).Le dispositif est de préférence enfermé dans le pneumatique au niveau de son plan équatorial (PE). Une microplaquette du transpondeur possède au moins la faculté de gérer et de transmettre des données relatives à la pression du pneumatique.
Patent EP-0859298-B1 (EP)
Inventor: KENTENICH WALTER
IPC: G05B19/042
Filed: 1998-01-17
Granted: 2007-04-25
Abstract: The controller includes a drive for e.g. actuating a garage door (18) which has a motor (60) and a coupling (17). The motor is connected to a control module (11) that responds to inputs from a number of devices (62-80) that provide different functions, such as remote control, and emergency stop. The adjustment of parameters is made using a front panel input (30) coupled to a processor (12).
Patent EP-0861950-B1 (EP)
Inventor: PIELMEIER GUENTER
IPC: E04B2/96
Filed: 1998-02-19
Granted: 2004-12-29
Abstract: The profile connecting component (2) is connected on the one hand with a profile (5a) and on the other hand with a retainer (1) fixable rotatively, pivotably and in various directions to a ridge rafter (4a). The profile connecting component at its upper end has a ball head (8) for insertion in the accommodation (9) of the retainer (1) and at its lower end fixture devices (7) for the profile (5a). The ball head of the profile connecting component is fixable in the accommodation of the retainer by means of a clamp pin (3) in an arbitrary direction to the ridge rafter (4a).
Patent EP-0882578-B1 (EP)
Inventor: PERUZZO LORENZO
IPC: C09J161/06
Filed: 1998-05-15
Granted: 2006-04-12
Abstract: A use of phenolic resins, particularly resol, as impregnating agents for clusters of fibers made of thermoplastic materials, for example polyester, in the production of stratified products and/or in sheaths for waterproofing.
Patent EP-0942096-B1 (EP)
Inventor: PAKUSA NORBERT
IPC: D06F81/04
Filed: 1998-12-22
Granted: 2003-03-12
Abstract: The ironing board (1) features an inclination adjusting device (12) to produce a diagonal position for the ironing plate (2) across the longitudinal axis. The inclination adjuster (12) is combined with a height adjusting device (3).
Patent EP-0905466-B1 (EP)
Inventor: FOX PETER
IPC: F28F1/04
Filed: 1998-09-01
Granted: 2003-11-19
Abstract: A water cooled panel (1), e.g. for metallurgical use, is constructed from a plurality of rectangular hollow section tube lengths (2), with adjacent tube lengths oriented corner-to-corner in a diamond array, with geometrical diagonals (4) of the tubes in a common plane (5), or generally so, and with means (6, 7, 12) to secure the tubes in such orientation, and with means (14 - 20) to ensure water flow communication between an end portion of one tube length (2) and an end portion of an adjacent tube length (2). <IMAGE>
Patent EP-0981366-B1 (EP)
Inventor: BIRD JOHN
IPC: A61K31/4015
Filed: 1998-03-03
Granted: 2004-01-21
Abstract: The subject invention pertains to matrix metalloproteinase (MMP) inhibitors that exhibit an IC50 of below 10<-4>M against MMP and have substantially no activity against non-MMP metalloproteinase-related events. The MMP inhibitors of the invention have reduced side-effects, especially with respect to joint pain.
Patent EP-0979523-B1 (EP)
Inventor: SUTTERLIN PHILIP H
IPC: H05B37/02
Filed: 1998-04-06
Granted: 2003-08-27
Abstract: A module (10) for interconnecting an AC power line (15) to a load (11) such as a lamp, which includes a first switch (12). The module (10) detects the state of the first switch (12) and then provides power to the load (11) when the switch is closed. Sequentially opening and closing the first switch (12) can be used as a command to dim the lamp. The module may also include a transceiver (20) which communicates the state of the switch to the other modules thereby allowing a plurality of devices to be controlled by the first switch (12).
Patent EP-0981805-B1 (EP)
Inventor: RICHARDS TIMOTHY PHILIP
IPC: G06K19/073
Filed: 1998-05-14
Granted: 2003-04-09
Abstract: L'invention porte sur une carte à circuit intégré possédant un mode de fonctionnement associé et comprenant: un microprocesseur, une mémoire couplée au microprocesseur; des données mises en mémoire représentant le mode de fonctionnement; un système d'exploitation mis en mémoire pour traiter les informations sélectionnées dans un premier format de carte à circuit intégré; un interpréteur mis en mémoire pour traiter les informations sélectionnées dans un second format de carte à circuit intégré; et un moyen d'acheminement des informations sélectionnées soit vers le système d'exploitation, soit vers l'interpréteur réagissant au mode de fonctionnement. Les informations sélectionnées peuvent être une commande telle qu'une commande d'accès aux fichiers.
Patent EP-0937684-B1 (EP)
Title: Hydrogenotitanates de lithium et leur procede de fabrication
Inventor: ATSUMI YOSHINORI
IPC: C01G23/00
Filed: 1998-07-15
Granted: 2011-05-04
Abstract: Hydrogénotitanates de lithium que l'on prépare par traitement acide du titanate de lithium et qui ont un pH de 11,2 ou inférieur; et hydrogénotitanates de lithium représentés par la formule générale HxLiy-xTizO4 (dans laquelle y≥x≥0; 0,8≤y≤2,7 et 1,3≤z≤2,2). Ces hydrogénotitanates de lithium sont utiles comme matériaux actifs d'électrodes positives ou négatives destinées à des batteries secondaires de type électrolytes non aqueux, et peuvent avoir une capacité de charge dépassant la capacité théorique. Ils peuvent se présenter sous la forme de particules qui de préférence contiennent des vides. Ils ont de préférence un diamètre particulaire maximum compris entre 0,1 et 50 νm et une surface spécifique comprise entre 0,01 et 300 m2/g. On peut les préparer en mettant un titanate de lithium en contact avec un acide tel que l'acide acétique, de façon à remplacer certains ions lithium par des protons.
Patent EP-1021864-B1 (EP)
Inventor: MILLER ROBIN MIHEKUN
IPC: H04B1/38
Filed: 1998-08-03
Granted: 2003-07-09
Abstract: La présente invention concerne un dispositif de commande à plusieurs interrupteurs utile pour commander une variété de fonctions dans une variété de sous-systèmes ou de dispositifs périphériques de véhicules. Le dispositif de commande comprend une partie base qui est spécialement profilée de manière à augmenter sa fonctionalité sans distraire le conducteur lorsqu'il roule. Dans un des modes de réalisation, plusieurs gorges recevant les doigts de l'utilisateur du dispositif comportent chacune un interrupteur facilement utilisable par un sujet, quelle que soit la taille de ses doigts. Un second mode de réalisation comprend des nervures surélevées ou gorges fournissant une indication tactile sur la position des doigts de l'utilisateur sur le dispositif. Les parties profilées permettent à l'utilisateur de régler un sous-système de véhicule sélectionné grâce à la technologie classique des touches à effleurement.
Patent EP-1027692-B1 (EP)
Inventor: WHALEN EDWARD E
IPC: B42D15/00
Filed: 1998-07-30
Granted: 2001-11-14
Abstract: A global time calculator includes an insert and a sleeve. The insert is marked on both its sides (or on a single page slide insert on one side) with vertical columns of incremental time designations, and may or may not contain a stop mechanism. The insert is slidable and connected with the sleeve so as to be shiftable in a vertical direction. Both sides of the sleeve (or in some embodiments a single side of the sleeve) have areas for obscuring vertically aligned time designations that are in excess of unobscured time designations.
Patent EP-0935484-B1 (EP)
Inventor: BAYS ROLAND
IPC: A61B18/22
Filed: 1998-08-28
Granted: 2005-03-23
Abstract: Le dispositif (100) pour l'irradiation de cavités intérieures de l'organisme comprend un cathéter souple (11), réalisé en un matériau transparent, contenant une fibre optique (13) dont un tronçon d'extrémité (18) est agencé pour diffuser radialement de la lumière provenant d'une source ménagée à l'autre extrémité de la fibre, et un ballonnet gonflable (140) fixé à une extrémité du cathéter de façon à recouvrir le tronçon diffusant (18) de la fibre optique (13). Le ballonnet (140) est réalisé en un matériau élastomère diffusant partiellement la lumière et préfabriqué par moulage d'une empreinte spécifique de la cavité à traiter, de manière à en épouser la forme. Il plaque bien contre la paroi de la cavité, l'épaisseur de ses parois reste constante après le gonflage, et la pression nécessaire à ce gonflage est faible et ne peut pas endommager les tissus de la cavité.
Patent EP-1004066-B1 (EP)
Inventor: SCHMID WERNER
IPC: G05D16/20
Filed: 1998-07-25
Granted: 2002-03-06
Abstract: L'invention concerne une soupape de régulation de pression (10, 10a) qui combine les propriétés fonctionnelles d'une soupape de régulation de pression et celles d'une soupape de commande. Cette soupape de régulation de pression (10, 10a) peut être employée en particulier pour commander des boîtes automatiques dans des véhicules à moteur, et se distingue par de faibles coûts de production, de faibles pertes, et une plage de fonctionnement élargie en direction des faibles pressions de service et présentant une courbe caractéristique constante. L'élément soupape (11) de la soupape de régulation de pression (10, 10a) présente une première soupape à siège (45) avec un élément de fermeture (34). Ce dernier (34) coopère avec un organe d'actionnement (35, 35a) qui présente une arête de commande (50) pour former une deuxième soupape à siège (49).
Patent EP-1047475-B1 (EP)
Inventor: GUPTA SUNEEL K
IPC: A61N1/32
Filed: 1998-12-02
Granted: 2007-02-21
Abstract: The present invention is an apparatus and method that maintains a constant drug delivery rate for an electrotransport delivery system, while the apparent transport efficiency of the system varies, by making adjustments to the output current of the system. More specifically, the constant drug delivery rate is maintained by the regulator of the electrotransport delivery system automatically adjusting the output current to compensate for the varying apparent transport efficiency.
Patent EP-0923151-B1 (EP)
Inventor: IVANOV EUGENE NIKOLAY
IPC: H01P1/30
Filed: 1993-06-01
Granted: 2002-05-08
Abstract: A dielectrically loaded cavity resonator operable at or near ambient temperatures. The resonator has a desired operating frequency and is dimensioned to operate at a moderate azimuthal mode at this desired operating frequency. The resonator has a dielectric disposed within a cavity dimensioned relative to the dielectric and coupled to provide a Q-factor proximate or substantially commensurate to the maximum possible Q-factor of the resonator for the desired port coupling at the azimuthal mode <IMAGE>